methacetin has been researched along with Hepatocellular Carcinoma in 5 studies
methacetin: RN given refers to parent cpd
methacetin : A member of the class of acetamides that is paracetamol in which the hydrogen of phenolic hydroxy group has been replaced by a methyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Methacetin metabolism was significantly decreased following TACE (-28%, P < 0." | 2.74 | Liver function as assessed by breath tests in patients with hepatocellular carcinoma. ( Grattagliano, I; Minerva, F; Palasciano, G; Palmieri, VO; Pollice, S; Portincasa, P, 2009) |
"Thirty-nine patients with primary liver cancer, 16 patients with hepatic metastasis and 14 healthy volunteers serving as controls were included in this study." | 2.74 | [The value of studying liver function reserve in hepatic carcinoma by 13C-methacetin breath test]. ( Feng, QL; Li, HX; Wang, JP; Yang, Y; Zhang, J, 2009) |
"20 patients with intermediate-stage hepatocellular carcinoma (HCC) received a LiMAx test 24 h pre and post TACE." | 1.62 | Prediction of transarterial chemoembolization (TACE) outcome by pre- and postinterventional 13C-methacetin breath test. ( Bäumler, W; Haimerl, M; Rio Bartulos, C; Senk, K; Stroszczynski, C; Verloh, N; Wiggermann, P; Wilcke, J, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Senk, K | 1 |
Wilcke, J | 1 |
Haimerl, M | 1 |
Verloh, N | 1 |
Rio Bartulos, C | 1 |
Bäumler, W | 1 |
Stroszczynski, C | 1 |
Wiggermann, P | 1 |
Gairing, SJ | 1 |
Kuchen, R | 1 |
Müller, L | 1 |
Cankaya, A | 1 |
Weerts, J | 1 |
Kapucu, A | 1 |
Sachse, S | 1 |
Zimpel, C | 1 |
Stoehr, F | 1 |
Pitton, MB | 1 |
Mittler, J | 1 |
Straub, BK | 1 |
Marquardt, JU | 1 |
Schattenberg, JM | 1 |
Labenz, C | 1 |
Kloeckner, R | 1 |
Weinmann, A | 1 |
Galle, PR | 1 |
Wörns, MA | 1 |
Foerster, F | 1 |
Palmieri, VO | 1 |
Grattagliano, I | 1 |
Minerva, F | 1 |
Pollice, S | 1 |
Palasciano, G | 1 |
Portincasa, P | 1 |
Li, HX | 1 |
Wang, JP | 1 |
Yang, Y | 1 |
Zhang, J | 1 |
Feng, QL | 1 |
Matsumoto, K | 1 |
Suehiro, M | 1 |
Iio, M | 1 |
Kawabe, T | 1 |
Shiratori, Y | 1 |
Okano, K | 1 |
Sugimoto, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis[NCT00244569] | Phase 3 | 120 participants (Anticipated) | Interventional | 2005-09-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for methacetin and Hepatocellular Carcinoma
Article | Year |
---|---|
Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Breath Tests; Carbon Isotopes; Carcinoma, Hepatocellular | 2009 |
[The value of studying liver function reserve in hepatic carcinoma by 13C-methacetin breath test].
Topics: Acetamides; Aged; Aged, 80 and over; Breath Tests; Carcinoma, Hepatocellular; Case-Control Studies; | 2009 |
3 other studies available for methacetin and Hepatocellular Carcinoma
Article | Year |
---|---|
Prediction of transarterial chemoembolization (TACE) outcome by pre- and postinterventional 13C-methacetin breath test.
Topics: Acetamides; Breath Tests; Carbon Isotopes; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic | 2021 |
13 C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Topics: Albumins; Bilirubin; Breath Tests; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; End St | 2022 |
[13C]methacetin breath test for evaluation of liver damage.
Topics: Acetamides; Adult; Breath Tests; Carbon Dioxide; Carcinoma, Hepatocellular; Female; Humans; Liver Ci | 1987 |